The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest acute myeloid leukemia market share in 2022.

The global acute myeloid leukemia market is expected to grow from $1.15 billion in 2022 to $1.29 billion in 2023 at a compound annual growth rate (CAGR) of 12.38%. The acute myeloid leukemia market size is expected to grow to $2.03 billion in 2027 at a CAGR of 12.03%.

Major Driver In The Acute Myeloid Leukemia Market ­– Increase In The Older Population Base And Growing Unmet Healthcare Needs
According to the American Cancer Society USA (ACS), a statewide nonprofit health organization, AML was widespread in senior persons in 2022, with an average age at diagnosis of 68, and survival of elderly AML patients remained very low. In 2022, it afflicted around 60,650 persons and resulted in 24000 deaths. As a result, the gelatin market is driven by the aging population and growing unmet healthcare needs.

View More On The Acute Myeloid Leukemia Market Report 2023 – https://www.thebusinessresearchcompany.com/report/acute-myeloid-leukemia-global-market-report

Key Acute Myeloid Leukemia Market Segments
1) By Treatment Type: Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy
2) By Chemotherapy: Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy
3) By Regimen: DC Regimen, AVD Regimen, VCD Regimen
4) By End-User: Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics

Recent Acute Myeloid Leukemia Market Trend – Growing Investments In R&D
For example, in April 2020, Ryvu, a biopharmaceutical business based in Poland, teamed with Menarini, an Italian pharmaceutical company, to complete the Phase I part of the Phase I/II study in acute myeloid leukemia (AML) and deliver the first-ever data with an in-house generated asset.

Acute Myeloid Leukemia Market Prominent Players
Major players in the acute myeloid leukemia market are Pfizer Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Bristol Myers Squibb, Amgen Inc., Celgene Corporation, and Ambit Biosciences Corporation, Takeda Pharmaceuticals.

Request A Sample Of The Global Acute Myeloid Leukemia Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6100&type=smp

The Acute Myeloid Leukemia Global Market Report 2023 provides a comprehensive overview on the acute myeloid leukemia market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the acute myeloid leukemia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Acute myeloid leukemia (AML) is a blood malignancy caused by aberrant white blood cells in the bone marrow. AML is distinguished by myeloblasts, also known as leukaemic blasts, or the excessive generation of immature white blood cells. These cells clog the bone marrow, preventing it from creating healthy blood cells.

View More Related Reports –
https://www.thebusinessresearchcompany.com/sample.aspx?id=6100&type=smp

Skin Cancer Drugs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Lung Cancer Drugs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model